Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:36 pm Purchase |
2024-09-30 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 2,433,168 8.200% |
400 (+0.02%) |
Filing History |
| 2024-10-02 4:30 pm Sale |
2024-10-01 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 1,237,909 2.560% |
-1,410,563 (-53.26%) |
Filing History |
| 2024-09-06 4:59 pm Sale |
2024-08-19 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,648,472 5.500% |
-1,252,842 (-32.11%) |
Filing History |
| 2024-04-16 09:15 am Sale |
2024-04-05 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 3,901,314 8.100% |
-319,083 (-7.56%) |
Filing History |
| 2024-02-02 09:20 am Purchase |
2023-12-31 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 2,432,768 9.300% |
63,765 (+2.69%) |
Filing History |
| 2023-02-14 08:22 am Purchase |
2022-12-31 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 2,369,003 9.500% |
60,000 (+2.60%) |
Filing History |
| 2023-01-09 5:00 pm Purchase |
2022-06-24 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 4,220,397 9.200% |
1,972,873 (+87.78%) |
Filing History |
| 2022-02-10 5:02 pm Sale |
2021-12-31 | 13G | Galecto, Inc. GLTO |
Soleus Private Equity Fund I L.P. | 0 0.000% |
-60,506 (Position Closed) |
Filing History |
| 2022-02-10 5:00 pm Purchase |
2021-12-31 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 2,309,003 9.500% |
473,663 (+25.81%) |
Filing History |
| 2021-11-01 5:16 pm Purchase |
2021-04-26 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 1,835,340 7.600% |
1,835,340 (New Position) |
Filing History |
| 2021-09-03 5:16 pm Sale |
2021-08-24 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,247,524 6.950% |
-546,709 (-19.57%) |
Filing History |
| 2021-06-28 4:32 pm Sale |
2021-06-17 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,794,233 8.690% |
-400,000 (-12.52%) |
Filing History |
| 2021-02-12 5:12 pm Sale |
2020-12-31 | 13G | Galecto, Inc. GLTO |
Soleus Private Equity Fund I L.P. | 60,506 5.990% |
-216 (-0.36%) |
Filing History |
| 2020-12-28 4:30 pm Purchase |
2020-12-15 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 3,194,233 9.930% |
3,194,233 (New Position) |
Filing History |
| 2020-11-12 09:02 am Purchase |
2020-11-02 | 13G | Galecto, Inc. GLTO |
Soleus Private Equity Fund I L.P. | 60,722 6.170% |
60,722 (New Position) |
Filing History |